{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:53:39Z","timestamp":1791402819966,"version":"4.3.3"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2017R1C1B2004423"],"award-info":[{"award-number":["2017R1C1B2004423"]}],"id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2017R1A5A2015541"],"award-info":[{"award-number":["2017R1A5A2015541"]}],"id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12272-019-01178-1","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T01:31:29Z","timestamp":1569893489000},"page":"935-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-5857","authenticated-orcid":false,"given":"Yoon Seok","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"1178_CR85","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","volume":"91","author":"M Aharoni-Simon","year":"2011","unstructured":"Aharoni-Simon M, Hann-Obercyger M, Pen S, Madar Z, Tirosh O (2011) Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice. Lab Invest 91:1018\u20131028","journal-title":"Lab Invest"},{"key":"1178_CR1","doi-asserted-by":"publisher","first-page":"8515343","DOI":"10.1155\/2018\/8515343","volume":"2018","author":"O Ali","year":"2018","unstructured":"Ali O, Darwish HA, Eldeib KM, Abdel Azim SA (2018) miR-26a potentially contributes to the regulation of fatty acid and sterol metabolism in vitro human HepG2 cell model of nonalcoholic fatty liver disease. Oxid Med Cell Longev 2018:8515343","journal-title":"Oxid Med Cell Longev"},{"key":"1178_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.febslet.2004.06.045","volume":"571","author":"J Asin-Cayuela","year":"2004","unstructured":"Asin-Cayuela J, Manas AR, James AM, Smith RA, Murphy MP (2004) Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 571:9\u201316","journal-title":"FEBS Lett"},{"key":"1178_CR3","first-page":"109","volume":"5","author":"M Babbar","year":"2013","unstructured":"Babbar M, Sheikh MS (2013) Metabolic stress and disorders related to alterations in mitochondrial fission or fusion. Mol Cell Pharmacol 5:109\u2013133","journal-title":"Mol Cell Pharmacol"},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche K, Igoudjil A, Pessayre D, Fromenty B (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6:1\u201328","journal-title":"Mitochondrion"},{"key":"1178_CR86","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1472-8206.2009.00765.x","volume":"24","author":"K Begriche","year":"2010","unstructured":"Begriche K, Massart J, Fromenty B (2010) Effects of beta-aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity. Fundam Clin Pharmacol 24:269\u2013282","journal-title":"Fundam Clin Pharmacol"},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","volume":"54","author":"K Begriche","year":"2011","unstructured":"Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773\u2013794","journal-title":"J Hepatol"},{"key":"1178_CR6","first-page":"221","volume":"7","author":"A Berlanga","year":"2014","unstructured":"Berlanga A, Guiu-Jurado E, Porras JA, Auguet T (2014) Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol 7:221\u2013239","journal-title":"Clin Exp Gastroenterol"},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/med.21515","volume":"39","author":"J Cai","year":"2019","unstructured":"Cai J, Zhang XJ, Li H (2019) Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Med Res Rev 39:328\u2013348","journal-title":"Med Res Rev"},{"key":"1178_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1572-0241.2007.01709.x","volume":"103","author":"C Carter-Kent","year":"2008","unstructured":"Carter-Kent C, Zein NN, Feldstein AE (2008) Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 103:1036\u20131042","journal-title":"Am J Gastroenterol"},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","volume":"274","author":"KD Chavin","year":"1999","unstructured":"Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, Huang CC, Wu TC, Lane MD, Diehl AM (1999) Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274:5692\u20135700","journal-title":"J Biol Chem"},{"key":"1178_CR87","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1021\/acs.jmedchem.7b01182","volume":"61","author":"ES Childress","year":"2018","unstructured":"Childress ES, Alexopoulos SJ, Hoehn KL, Santos WL (2018) Small molecule mitochondrial uncouplers and their therapeutic potential. J Med Chem 61:4641\u20134655","journal-title":"J Med Chem"},{"key":"1178_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF (1998) Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114:842\u2013845","journal-title":"Gastroenterology"},{"key":"1178_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","volume":"28","author":"EA Day","year":"2017","unstructured":"Day EA, Ford RJ, Steinberg GR (2017) AMPK as a therapeutic target for treating metabolic diseases. Trends Endocrinol Metab 28:545\u2013560","journal-title":"Trends Endocrinol Metab"},{"key":"1178_CR12","doi-asserted-by":"publisher","first-page":"37575","DOI":"10.1074\/jbc.M404003200","volume":"279","author":"A Dhanasekaran","year":"2004","unstructured":"Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, Keszler A, Joseph J, Kalyanaraman B (2004) Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem 279:37575\u201337587","journal-title":"J Biol Chem"},{"key":"1178_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2005.04.016","volume":"39","author":"A Dhanasekaran","year":"2005","unstructured":"Dhanasekaran A, Kotamraju S, Karunakaran C, Kalivendi SV, Thomas S, Joseph J, Kalyanaraman B (2005) Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic Biol Med 39:567\u2013583","journal-title":"Free Radic Biol Med"},{"key":"1178_CR88","doi-asserted-by":"publisher","first-page":"42379","DOI":"10.1074\/jbc.M112.413682","volume":"287","author":"WX Ding","year":"2012","unstructured":"Ding WX, Guo F, Ni HM, Bockus A, Manley S, Stolz DB, Eskelinen EL, Jaeschke H, Yin XM (2012) Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem 287:42379\u201342388","journal-title":"J Biol Chem"},{"key":"1178_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/ars.2010.3395","volume":"15","author":"HB Eccleston","year":"2011","unstructured":"Eccleston HB, Andringa KK, Betancourt AM, King AL, Mantena SK, Swain TM, Tinsley HN, Nolte RN, Nagy TR, Abrams GA, Bailey SM (2011) Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. Antioxid Redox Signal 15:447\u2013459","journal-title":"Antioxid Redox Signal"},{"key":"1178_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331:456\u2013461","journal-title":"Science"},{"key":"1178_CR16","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.4049\/jimmunol.1000889","volume":"185","author":"A Elsheikh","year":"2010","unstructured":"Elsheikh A, Lavergne SN, Castrejon JL, Farrell J, Wang H, Sathish J, Pichler WJ, Park BK, Naisbitt DJ (2010) Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. J Immunol 185:6448\u20136460","journal-title":"J Immunol"},{"key":"1178_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3109\/10715762.2014.945079","volume":"48","author":"C Feillet-Coudray","year":"2014","unstructured":"Feillet-Coudray C, Fouret G, Ebabe Elle R, Rieusset J, Bonafos B, Chabi B, Crouzier D, Zarkovic K, Zarkovic N, Ramos J, Badia E, Murphy MP, Cristol JP, Coudray C (2014) The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol. Free Radic Res 48:1232\u20131246","journal-title":"Free Radic Res"},{"key":"1178_CR89","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41419-017-0023-6","volume":"9","author":"R Filadi","year":"2018","unstructured":"Filadi R, Pendin D, Pizzo P (2018) Mitofusin 2: from functions to disease. Cell Death Dis 9:330","journal-title":"Cell Death Dis"},{"key":"1178_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbabio.2015.05.019","volume":"1847","author":"G Fouret","year":"2015","unstructured":"Fouret G, Tolika E, Lecomte J, Bonafos B, Aoun M, Murphy MP, Ferreri C, Chatgilialoglu C, Dubreucq E, Coudray C, Feillet-Coudray C (2015) The mitochondrial-targeted antioxidant, MitoQ, increases liver mitochondrial cardiolipin content in obesogenic diet-fed rats. Biochim Biophys Acta 1847:1025\u20131035","journal-title":"Biochim Biophys Acta"},{"key":"1178_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","volume":"67","author":"B Fromenty","year":"1995","unstructured":"Fromenty B, Pessayre D (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67:101\u2013154","journal-title":"Pharmacol Ther"},{"key":"1178_CR20","doi-asserted-by":"publisher","first-page":"G632","DOI":"10.1152\/ajpgi.00182.2014","volume":"307","author":"CA Galloway","year":"2014","unstructured":"Galloway CA, Lee H, Brookes PS, Yoon Y (2014) Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 307:G632\u2013641","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1178_CR21","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jhep.2014.07.024","volume":"61","author":"LT Gan","year":"2014","unstructured":"Gan LT, Van Rooyen DM, Koina ME, McCuskey RS, Teoh NC, Farrell GC (2014) Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. J Hepatol 61:1376\u20131384","journal-title":"J Hepatol"},{"key":"1178_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI83885","volume":"126","author":"I Garcia-Martinez","year":"2016","unstructured":"Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, Shlomchik MJ, Coffman RL, Candia A, Mehal WZ (2016) Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest 126:859\u2013864","journal-title":"J Clin Invest"},{"key":"1178_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3109\/10715762.2013.830717","volume":"47","author":"C Garcia-Ruiz","year":"2013","unstructured":"Garcia-Ruiz C, Baulies A, Mari M, Garcia-Roves PM, Fernandez-Checa JC (2013) Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res 47:854\u2013868","journal-title":"Free Radic Res"},{"key":"1178_CR24","doi-asserted-by":"publisher","first-page":"637027","DOI":"10.1155\/2014\/637027","volume":"2014","author":"AM Gusdon","year":"2014","unstructured":"Gusdon AM, Song KX, Qu S (2014) Nonalcoholic fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. Oxid Med Cell Longev 2014:637027","journal-title":"Oxid Med Cell Longev"},{"key":"1178_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.26946","volume":"60","author":"P Handa","year":"2014","unstructured":"Handa P, Maliken BD, Nelson JE, Morgan-Stevenson V, Messner DJ, Dhillon BK, Klintworth HM, Beauchamp M, Yeh MM, Elfers CT, Roth CL, Kowdley KV (2014) Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. Hepatology 60:133\u2013145","journal-title":"Hepatology"},{"key":"1178_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0033-1358522","volume":"33","author":"A Henkel","year":"2013","unstructured":"Henkel A, Green RM (2013) The unfolded protein response in fatty liver disease. Semin Liver Dis 33:321\u2013329","journal-title":"Semin Liver Dis"},{"key":"1178_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121\u2013135","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1178_CR28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/sj.bjp.0707189","volume":"150","author":"SA Hinke","year":"2007","unstructured":"Hinke SA, Martens GA, Cai Y, Finsi J, Heimberg H, Pipeleers D, Van de Casteele M (2007) Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer. Br J Pharmacol 150:1031\u20131043","journal-title":"Br J Pharmacol"},{"key":"1178_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/14740338.2017.1343299","volume":"16","author":"D Issa","year":"2017","unstructured":"Issa D, Wattacheril J, Sanyal AJ (2017) Treatment options for nonalcoholic steatohepatitis\u2014a safety evaluation. Expert Opin Drug Saf 16:903\u2013913","journal-title":"Expert Opin Drug Saf"},{"key":"1178_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.nut.2014.01.016","volume":"30","author":"HF Ji","year":"2014","unstructured":"Ji HF, Sun Y, Shen L (2014) Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis. Nutrition 30:986\u2013991","journal-title":"Nutrition"},{"key":"1178_CR31","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1038\/srep16262","volume":"5","author":"J Ji","year":"2015","unstructured":"Ji J, Qin Y, Ren J, Lu C, Wang R, Dai X, Zhou R, Huang Z, Xu M, Chen M, Wu W, Song L, Shen H, Hu Z, Miao D, Xia Y, Wang X (2015) Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN. Sci Rep 5:16262","journal-title":"Sci Rep"},{"key":"1178_CR90","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nchembio727","volume":"1","author":"VE Kagan","year":"2005","unstructured":"Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova, II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG (2005) Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1:223\u2013232","journal-title":"Nat Chem Biol"},{"key":"1178_CR91","first-page":"E101","volume":"240","author":"ML Kaplan","year":"1981","unstructured":"Kaplan ML, Leveille GA (1981) Development of lipogenesis and insulin sensitivity in tissues of the ob\/ob mouse. Am J Physiol 240:E101\u2013107","journal-title":"Am J Physiol"},{"key":"1178_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1101\/gad.1177604","volume":"18","author":"DP Kelly","year":"2004","unstructured":"Kelly DP, Scarpulla RC (2004) Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18:357\u2013368","journal-title":"Genes Dev"},{"key":"1178_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","volume":"68","author":"MA Konerman","year":"2018","unstructured":"Konerman MA, Jones JC, Harrison SA (2018) Pharmacotherapy for NASH: current and emerging. J Hepatol 68:362\u2013375","journal-title":"J Hepatol"},{"key":"1178_CR108","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bbagen.2013.10.041","volume":"1840","author":"VN Kotiadis","year":"2014","unstructured":"Kotiadis VN, Duchen MR, Osellame LD (2014) Mitochondrial quality control and communications with the nucleus are important in maintaining mitochondrial function and cell health. Biochim Biophys Acta 1840:1254\u20131265","journal-title":"Biochim Biophys Acta"},{"key":"1178_CR109","first-page":"e157","volume":"15","author":"WG Land","year":"2015","unstructured":"Land WG (2015) The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine. Sultan Qaboos Univ Med J 15:e157\u2013170","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1178_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1124\/jpet.106.114546","volume":"321","author":"I Larosche","year":"2007","unstructured":"Larosche I, Letteron P, Fromenty B, Vadrot N, Abbey-Toby A, Feldmann G, Pessayre D, Mansouri A (2007) Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver. J Pharmacol Exp Ther 321:526\u2013535","journal-title":"J Pharmacol Exp Ther"},{"key":"1178_CR92","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1124\/jpet.109.160879","volume":"332","author":"I Larosche","year":"2010","unstructured":"Larosche I, Letteron P, Berson A, Fromenty B, Huang TT, Moreau R, Pessayre D, Mansouri A (2010) Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. J Pharmacol Exp Ther 332:886\u2013897","journal-title":"J Pharmacol Exp Ther"},{"key":"1178_CR35","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","volume":"305","author":"JE Lavine","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Unalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR (2011) Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 305:1659\u20131668","journal-title":"JAMA"},{"key":"1178_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/17474124.2017.1293523","volume":"11","author":"N Lazaridis","year":"2017","unstructured":"Lazaridis N, Tsochatzis E (2017) Current and future treatment options in non-alcoholic steatohepatitis (NASH). Expert Rev Gastroenterol Hepatol 11:357\u2013369","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1178_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0973-6883(12)60104-2","volume":"2","author":"TA Le","year":"2012","unstructured":"Le TA, Loomba R (2012) Management of non-alcoholic fatty liver disease and steatohepatitis. J Clin Exp Hepatol 2:156\u2013173","journal-title":"J Clin Exp Hepatol"},{"key":"1178_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.toxlet.2017.06.005","volume":"277","author":"J Lee","year":"2017","unstructured":"Lee J, Homma T, Fujii J (2017a) Mice in the early stage of liver steatosis caused by a high fat diet are resistant to thioacetamide-induced hepatotoxicity and oxidative stress. Toxicol Lett 277:92\u2013103","journal-title":"Toxicol Lett"},{"key":"1178_CR39","doi-asserted-by":"crossref","first-page":"63370","DOI":"10.18632\/oncotarget.18812","volume":"8","author":"S Lee","year":"2017","unstructured":"Lee S, Kim S, Hwang S, Cherrington NJ, Ryu DY (2017b) Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver disease. Oncotarget 8:63370\u201363381","journal-title":"Oncotarget"},{"key":"1178_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","volume":"55","author":"JR Lewis","year":"2010","unstructured":"Lewis JR, Mohanty SR (2010) Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55:560\u2013578","journal-title":"Dig Dis Sci"},{"key":"1178_CR111","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2010.07.003","volume":"12","author":"J Li","year":"2010","unstructured":"Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, Sun C, Liu X, Jefferson LS, Xiong J, Lanoue KF, Chang Z, Lynch CJ, Wang H, Shi Y (2010) Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 12:154\u2013165","journal-title":"Cell Metab"},{"key":"1178_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4166\/kjg.2010.55.6.384","volume":"55","author":"CY Lim","year":"2010","unstructured":"Lim CY, Jun DW, Jang SS, Cho WK, Chae JD, Jun JH (2010) Effects of carnitine on peripheral blood mitochondrial DNA copy number and liver function in non-alcoholic fatty liver disease. Korean J Gastroenterol 55:384\u2013389","journal-title":"Korean J Gastroenterol"},{"key":"1178_CR93","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/79697","volume":"6","author":"HZ Lin","year":"2000","unstructured":"Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM (2000) Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6:998\u20131003","journal-title":"Nat Med"},{"key":"1178_CR94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10863-017-9727-7","volume":"49","author":"H Liu","year":"2017","unstructured":"Liu H, Dai C, Fan Y, Guo B, Ren K, Sun T, Wang W (2017) From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases. J Bioenerg Biomembr 49:413\u2013422","journal-title":"J Bioenerg Biomembr"},{"key":"1178_CR42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686\u2013690","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1178_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T (2018) Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology 155:629\u2013647","journal-title":"Gastroenterology"},{"key":"1178_CR96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/BJ20080868","volume":"417","author":"SK Mantena","year":"2009","unstructured":"Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE, Kraus DW, Darley-Usmar VM, Bailey SM (2009) High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417:183\u2013193","journal-title":"Biochem J"},{"key":"1178_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","volume":"4","author":"M Mari","year":"2006","unstructured":"Mari M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, Garcia-Ruiz C (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4:185\u2013198","journal-title":"Cell Metab"},{"key":"1178_CR45","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/hep.25801","volume":"56","author":"PE Marques","year":"2012","unstructured":"Marques PE, Amaral SS, Pires DA, Nogueira LL, Soriani FM, Lima BH, Lopes GA, Russo RC, Avila TV, Melgaco JG, Oliveira AG, Pinto MA, Lima CX, De Paula AM, Cara DC, Leite MF, Teixeira MM, Menezes GB (2012) Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 56:1971\u20131982","journal-title":"Hepatology"},{"key":"1178_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/hep.27216","volume":"61","author":"PE Marques","year":"2015","unstructured":"Marques PE, Oliveira AG, Pereira RV, David BA, Gomides LF, Saraiva AM, Pires DA, Novaes JT, Patricio DO, Cisalpino D, Menezes-Garcia Z, Leevy WM, Chapman SE, Mahecha G, Marques RE, Guabiraba R, Martins VP, Souza DG, Mansur DS, Teixeira MM, Leite MF, Menezes GB (2015) Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice. Hepatology 61:348\u2013360","journal-title":"Hepatology"},{"key":"1178_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","volume":"49","author":"JD McGarry","year":"1980","unstructured":"McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49:395\u2013420","journal-title":"Annu Rev Biochem"},{"key":"1178_CR48","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1128\/MCB.00677-14","volume":"34","author":"PJ Meakin","year":"2014","unstructured":"Meakin PJ, Chowdhry S, Sharma RS, Ashford FB, Walsh SV, McCrimmon RJ, Dinkova-Kostova AT, Dillon JF, Hayes JD, Ashford ML (2014) Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol Cell Biol 34:3305\u20133320","journal-title":"Mol Cell Biol"},{"key":"1178_CR49","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.bbamcr.2015.05.010","volume":"1853","author":"S Melser","year":"2015","unstructured":"Melser S, Lavie J, Benard G (2015) Mitochondrial degradation and energy metabolism. Biochim Biophys Acta 1853:2812\u20132821","journal-title":"Biochim Biophys Acta"},{"key":"1178_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000336669","volume":"30","author":"S Milic","year":"2012","unstructured":"Milic S, Stimac D (2012) Nonalcoholic fatty liver disease\/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis 30:158\u2013162","journal-title":"Dig Dis"},{"key":"1178_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/157016307781483469","volume":"4","author":"P Mishra","year":"2007","unstructured":"Mishra P, Younossi ZM (2007) Current treatment strategies for non-alcoholic fatty liver disease (NAFLD). Curr Drug Discov Technol 4:133\u2013140","journal-title":"Curr Drug Discov Technol"},{"key":"1178_CR52","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.yjmcc.2009.03.003","volume":"46","author":"M Murgia","year":"2009","unstructured":"Murgia M, Giorgi C, Pinton P, Rizzuto R (2009) Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling. J Mol Cell Cardiol 46:781\u2013788","journal-title":"J Mol Cell Cardiol"},{"key":"1178_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1\u201313","journal-title":"Biochem J"},{"key":"1178_CR54","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.2174\/1381612811319290010","volume":"19","author":"G Musso","year":"2013","unstructured":"Musso G, Anty R, Petta S (2013) Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? Curr Pharm Des 19:5297\u20135313","journal-title":"Curr Pharm Des"},{"key":"1178_CR97","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.3390\/ijms15058713","volume":"15","author":"F Nassir","year":"2014","unstructured":"Nassir F, Ibdah JA (2014) Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci 15:8713\u20138742","journal-title":"Int J Mol Sci"},{"key":"1178_CR55","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.1111\/jcmm.13918","volume":"22","author":"H Nie","year":"2018","unstructured":"Nie H, Yu X, He H, Zhou L, Li Q, Song C, Wang D, Ren T, Chen Z, Huang H, Dai X, Zhou Y (2018) Hepatocyte miR-33a mediates mitochondrial dysfunction and hepatosteatosis by suppressing NDUFA5. J Cell Mol Med 22:6285\u20136293","journal-title":"J Cell Mol Med"},{"key":"1178_CR98","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.aaa0672","volume":"347","author":"RJ Perry","year":"2015","unstructured":"Perry RJ, Zhang D, Zhang XM, Boyer JL, Shulman GI (2015) Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347:1253\u20131256","journal-title":"Science"},{"issue":"Suppl 1","key":"1178_CR56","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","volume":"22","author":"D Pessayre","year":"2007","unstructured":"Pessayre D (2007) Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22(Suppl 1):S20\u201327","journal-title":"J Gastroenterol Hepatol"},{"key":"1178_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2001-12929","volume":"21","author":"D Pessayre","year":"2001","unstructured":"Pessayre D, Berson A, Fromenty B, Mansouri A (2001) Mitochondria in steatohepatitis. Semin Liver Dis 21:57\u201369","journal-title":"Semin Liver Dis"},{"key":"1178_CR58","doi-asserted-by":"publisher","first-page":"G193","DOI":"10.1152\/ajpgi.00426.2001","volume":"282","author":"D Pessayre","year":"2002","unstructured":"Pessayre D, Mansouri A, Fromenty B (2002) Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282:G193\u2013199","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1178_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/03602532.2011.604086","volume":"44","author":"D Pessayre","year":"2012","unstructured":"Pessayre D, Fromenty B, Berson A, Robin MA, Letteron P, Moreau R, Mansouri A (2012) Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 44:34\u201387","journal-title":"Drug Metab Rev"},{"key":"1178_CR60","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","volume":"23","author":"L Poulsen","year":"2012","unstructured":"Poulsen L, Siersbaek M, Mandrup S (2012) PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol 23:631\u2013639","journal-title":"Semin Cell Dev Biol"},{"key":"1178_CR61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/hep.20012","volume":"39","author":"K Promrat","year":"2004","unstructured":"Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH (2004) A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39:188\u2013196","journal-title":"Hepatology"},{"key":"1178_CR99","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.redox.2013.04.005","volume":"1","author":"CL Quinlan","year":"2013","unstructured":"Quinlan CL, Perevoshchikova IV, Hey-Mogensen M, Orr AL, Brand MD (2013) Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol 1:304\u2013312","journal-title":"Redox Biol"},{"key":"1178_CR100","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","volume":"52","author":"RS Rector","year":"2010","unstructured":"Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA (2010) Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52:727\u2013736","journal-title":"J Hepatol"},{"key":"1178_CR62","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2337\/db07-1318","volume":"57","author":"U Riserus","year":"2008","unstructured":"Riserus U, Sprecher D, Johnson T, Olson E, Hirschberg S, Liu A, Fang Z, Hegde P, Richards D, Sarov-Blat L, Strum JC, Basu S, Cheeseman J, Fielding BA, Humphreys SM, Danoff T, Moore NR, Murgatroyd P, O\u2019Rahilly S, Sutton P, Willson T, Hassall D, Frayn KN, Karpe F (2008) Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 57:332\u2013339","journal-title":"Diabetes"},{"key":"1178_CR63","doi-asserted-by":"publisher","first-page":"e2825","DOI":"10.1038\/cddis.2017.246","volume":"8","author":"PM Rodrigues","year":"2017","unstructured":"Rodrigues PM, Afonso MB, Simao AL, Carvalho CC, Trindade A, Duarte A, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM, Castro RE (2017) miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice. Cell Death Dis 8:e2825","journal-title":"Cell Death Dis"},{"key":"1178_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00232-008-9124-6","volume":"224","author":"TI Rokitskaya","year":"2008","unstructured":"Rokitskaya TI, Klishin SS, Severina II, Skulachev VP, Antonenko YN (2008) Kinetic analysis of permeation of mitochondria-targeted antioxidants across bilayer lipid membranes. J Membr Biol 224:9\u201319","journal-title":"J Membr Biol"},{"issue":"Suppl 1","key":"1178_CR115","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.2337\/diabetes.53.2007.S130","volume":"53","author":"S Rousset","year":"2004","unstructured":"Rousset S, Alves-Guerra MC, Mozo J, Miroux B, Cassard-Doulcier AM, Bouillaud F, Ricquier D (2004) The biology of mitochondrial uncoupling proteins. Diabetes 53(Suppl 1):S130\u2013S135","journal-title":"Diabetes"},{"key":"1178_CR65","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183\u20131192","journal-title":"Gastroenterology"},{"key":"1178_CR66","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.nut.2014.11.018","volume":"31","author":"K Sato","year":"2015","unstructured":"Sato K, Gosho M, Yamamoto T, Kobayashi Y, Ishii N, Ohashi T, Nakade Y, Ito K, Fukuzawa Y, Yoneda M (2015) Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Nutrition 31:923\u2013930","journal-title":"Nutrition"},{"key":"1178_CR67","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/gut.2007.147496","volume":"57","author":"G Serviddio","year":"2008","unstructured":"Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD, Sastre J, Vendemiale G, Altomare E (2008) Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 57:957\u2013965","journal-title":"Gut"},{"key":"1178_CR68","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1073\/pnas.0931245100","volume":"100","author":"RA Smith","year":"2003","unstructured":"Smith RA, Porteous CM, Gane AM, Murphy MP (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 100:5407\u20135412","journal-title":"Proc Natl Acad Sci USA"},{"key":"1178_CR69","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/hep.26461","volume":"58","author":"B Staels","year":"2013","unstructured":"Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, Baron M, Lucas A, Tailleux A, Hum DW, Ratziu V, Cariou B, Hanf R (2013) Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Hepatology 58:1941\u20131952","journal-title":"Hepatology"},{"key":"1178_CR70","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny NE, Parks EJ, Browning JD, Burgess SC (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804\u2013810","journal-title":"Cell Metab"},{"key":"1178_CR71","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","volume":"28","author":"NE Sunny","year":"2017","unstructured":"Sunny NE, Bril F, Cusi K (2017) Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies. Trends Endocrinol Metab 28:250\u2013260","journal-title":"Trends Endocrinol Metab"},{"key":"1178_CR72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","volume":"1821","author":"A Tailleux","year":"2012","unstructured":"Tailleux A, Wouters K, Staels B (2012) Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821:809\u2013818","journal-title":"Biochim Biophys Acta"},{"key":"1178_CR73","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1083\/jcb.201007013","volume":"191","author":"A Tanaka","year":"2010","unstructured":"Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, Youle RJ (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191:1367\u20131380","journal-title":"J Cell Biol"},{"key":"1178_CR74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jhep.2012.09.018","volume":"58","author":"G Tell","year":"2013","unstructured":"Tell G, Vascotto C, Tiribelli C (2013) Alterations in the redox state and liver damage: hints from the EASL basic school of hepatology. J Hepatol 58:365\u2013374","journal-title":"J Hepatol"},{"key":"1178_CR75","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.mito.2008.07.008","volume":"8","author":"JS Teodoro","year":"2008","unstructured":"Teodoro JS, Rolo AP, Duarte FV, Simoes AM, Palmeira CM (2008) Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion 8:367\u2013376","journal-title":"Mitochondrion"},{"key":"1178_CR76","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836\u20131846","journal-title":"Hepatology"},{"key":"1178_CR77","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1126\/science.aab4138","volume":"351","author":"EQ Toyama","year":"2016","unstructured":"Toyama EQ, Herzig S, Courchet J, Lewis TL Jr, Loson OC, Hellberg K, Young NP, Chen H, Polleux F, Chan DC, Shaw RJ (2016) Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351:275\u2013281","journal-title":"Science"},{"key":"1178_CR78","doi-asserted-by":"publisher","first-page":"31713","DOI":"10.1074\/jbc.M603422200","volume":"281","author":"S Uchiyama","year":"2006","unstructured":"Uchiyama S, Shimizu T, Shirasawa T (2006) CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem 281:31713\u201331719","journal-title":"J Biol Chem"},{"key":"1178_CR79","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Liu X, Nie J, Zhang J, Kimball SR, Zhang H, Zhang WJ, Jefferson LS, Cheng Z, Ji Q, Shi Y (2015) ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology 61:486\u2013496","journal-title":"Hepatology"},{"key":"1178_CR80","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1091\/mbc.E15-01-0036","volume":"26","author":"JA Willy","year":"2015","unstructured":"Willy JA, Young SK, Stevens JL, Masuoka HC, Wek RC (2015) CHOP links endoplasmic reticulum stress to NF-kappaB activation in the pathogenesis of nonalcoholic steatohepatitis. Mol Biol Cell 26:2190\u20132204","journal-title":"Mol Biol Cell"},{"key":"1178_CR101","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/hep.29689","volume":"67","author":"S Win","year":"2018","unstructured":"Win S, Than TA, Zhang J, Oo C, Min RWM, Kaplowitz N (2018) New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. Hepatology 67:2013\u20132024","journal-title":"Hepatology"},{"key":"1178_CR102","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fphys.2019.00411","volume":"10","author":"W Xiong","year":"2019","unstructured":"Xiong W, Ma Z, An D, Liu Z, Cai W, Bai Y, Zhan Q, Lai W, Zeng Q, Ren H, Xu D (2019) Mitofusin 2 participates in mitophagy and mitochondrial fusion against angiotensin II-induced cardiomyocyte injury. Front Physiol 10:411","journal-title":"Front Physiol"},{"issue":"588\u2013604","key":"1178_CR81","first-page":"e585","volume":"28","author":"T Yamada","year":"2018","unstructured":"Yamada T, Murata D, Adachi Y, Itoh K, Kameoka S, Igarashi A, Kato T, Araki Y, Huganir RL, Dawson TM, Yanagawa T, Okamoto K, Iijima M, Sesaki H (2018) Mitochondrial stasis reveals p62-mediated ubiquitination in Parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease. Cell Metab 28(588\u2013604):e585","journal-title":"Cell Metab"},{"key":"1178_CR82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3803\/EnM.2019.34.1.39","volume":"34","author":"HS Yi","year":"2019","unstructured":"Yi HS (2019) Implications of mitochondrial unfolded protein response and mitokines: a perspective on fatty liver diseases. Endocrinol Metab (Seoul) 34:39\u201346","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1178_CR103","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/JME-15-0101","volume":"55","author":"X Yin","year":"2015","unstructured":"Yin X, Zheng F, Pan Q, Zhang S, Yu D, Xu Z, Li H (2015) Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening. J Mol Endocrinol 55:169\u2013181","journal-title":"J Mol Endocrinol"},{"key":"1178_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41575-018-0094-6","volume":"16","author":"R Younes","year":"2019","unstructured":"Younes R, Bugianesi E (2019) A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD. Nat Rev Gastroenterol Hepatol 16:80\u201382","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1178_CR84","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104\u2013107","journal-title":"Nature"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-019-01178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-019-01178-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-019-01178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T23:04:54Z","timestamp":1601334294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-019-01178-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s12272-019-01178-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"assertion":[{"value":"17 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}